Table 2 Pharmacogenetic AC study patient demographics
Demographic | n | Parameters | Frequency (%) |
|---|---|---|---|
Follow-up | 230 | 63 months (median) | |
Age range | 230 | 57 years (median) | |
No. progressed | 230 | 25 | |
No. died | 230 | 15 | |
Ethinicity | 230 | European | 97 |
South Asian | 2 | ||
East Asian | <1 | ||
Histology | 229 | Ductal | 83 |
Lobular | 7 | ||
Mixed | 7 | ||
Other | 3 | ||
Focality | 229 | Unifocal | 86 |
Multifocal | 14 | ||
Tumour grade | 227 | I | 8 |
II | 43 | ||
III | 49 | ||
Tumour size | 229 | <20 mm | 44 |
20–49.9 mm | 51 | ||
⩾50 mm | 5 | ||
Involved nodes | 230 | 0 | 63 |
1–3 | 35 | ||
⩾4 | 3 | ||
ER status | 230 | Positive | 75 |
Negative | 25 | ||
PR status | 219 | Positive | 64 |
Negative | 36 | ||
ERBB2 status | 47 | Positive | 55 |
Negative | 43 | ||
Mixed | 2 |
